Microbot Medical (MBOT) Competitors $2.54 -0.08 (-3.05%) Closing price 04:00 PM EasternExtended Trading$2.59 +0.05 (+2.13%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. SMLR, NNOX, SMTI, STIM, SNWV, ZIMV, TCMD, NVRO, SKIN, and NYXHShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nevro (NVRO), Beauty Health (SKIN), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Semler Scientific Nano-X Imaging Sanara MedTech Neuronetics SANUWAVE Health ZimVie Tactile Systems Technology Nevro Beauty Health Nyxoah Semler Scientific (NASDAQ:SMLR) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Which has better valuation & earnings, SMLR or MBOT? Semler Scientific has higher revenue and earnings than Microbot Medical. Semler Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M8.89$20.58M-$2.61-17.20Microbot MedicalN/AN/A-$10.74M-$0.65-3.91 Which has more volatility & risk, SMLR or MBOT? Semler Scientific has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Is SMLR or MBOT more profitable? Semler Scientific has a net margin of 72.65% compared to Microbot Medical's net margin of 0.00%. Semler Scientific's return on equity of 50.77% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific72.65% 50.77% 47.04% Microbot Medical N/A -218.30%-158.17% Do analysts prefer SMLR or MBOT? Semler Scientific currently has a consensus price target of $71.00, indicating a potential upside of 58.16%. Microbot Medical has a consensus price target of $9.00, indicating a potential upside of 254.33%. Given Microbot Medical's higher possible upside, analysts plainly believe Microbot Medical is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer SMLR or MBOT? In the previous week, Semler Scientific had 6 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for Semler Scientific and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.05 beat Semler Scientific's score of 0.59 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Semler Scientific 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in SMLR or MBOT? 49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in SMLR or MBOT? Microbot Medical received 347 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 70.79% of users gave Microbot Medical an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote. CompanyUnderperformOutperformSemler ScientificOutperform Votes266.67% Underperform Votes133.33% Microbot MedicalOutperform Votes34970.79% Underperform Votes14429.21% SummarySemler Scientific beats Microbot Medical on 10 of the 15 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$92.40M$4.47B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E Ratio-3.1729.4326.8419.71Price / SalesN/A67.72391.39116.98Price / CashN/A51.0838.2534.62Price / Book6.686.236.794.50Net Income-$10.74M$68.16M$3.23B$248.18M7 Day Performance3.25%18.33%4.07%1.14%1 Month Performance13.90%23.04%12.52%15.18%1 Year Performance156.57%20.61%16.83%6.55% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical1.9287 of 5 stars$2.54-3.1%$9.00+254.3%+162.1%$92.40MN/A-3.1720Positive NewsEarnings ReportSMLRSemler Scientific2.5564 of 5 stars$34.84+0.1%$71.00+103.8%+78.4%$334.36M$56.29M7.10120Options VolumeGap UpHigh Trading VolumeNNOXNano-X Imaging1.4416 of 5 stars$5.56+6.1%$12.00+115.8%-43.7%$321.25M$11.28M-6.54190News CoverageUpcoming EarningsGap UpSMTISanara MedTech1.7872 of 5 stars$34.37+6.2%$48.50+41.1%-4.6%$305.48M$86.67M-34.7260Earnings ReportAnalyst RevisionHigh Trading VolumeSTIMNeuronetics1.9202 of 5 stars$4.14-6.5%$5.50+32.9%+69.6%$272.47M$74.89M-3.37180SNWVSANUWAVE HealthN/A$30.55+1.5%N/AN/A$261.17M$32.63M-6.7040ZIMVZimVie2.2495 of 5 stars$8.91+1.7%$19.50+118.9%-47.9%$248.12M$449.75M-0.682,700TCMDTactile Systems Technology3.409 of 5 stars$9.72+1.9%$16.00+64.6%-23.8%$230.03M$292.98M13.89980NVRONevro0.193 of 5 stars$5.85+0.1%$5.36-8.3%-44.4%$224.32M$408.52M-3.091,090News CoverageSKINBeauty Health0.3638 of 5 stars$1.76-5.9%$2.45+39.2%-34.7%$220.43M$322.47M-4.191,030Positive NewsGap DownHigh Trading VolumeNYXHNyxoah2.9175 of 5 stars$5.98-5.1%$14.50+142.5%-23.0%$203.68M$4.52M-3.20110Earnings ReportGap Up Related Companies and Tools Related Companies Semler Scientific Alternatives Nano-X Imaging Alternatives Sanara MedTech Alternatives Neuronetics Alternatives SANUWAVE Health Alternatives ZimVie Alternatives Tactile Systems Technology Alternatives Nevro Alternatives Beauty Health Alternatives Nyxoah Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.